Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients - Wikidata - awgldk - TriplyDB

Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients

Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients

http://www.wikidata.org/entity/Q34236633

about

Human polyomavirus reactivation: disease pathogenesis and treatment approaches The importance of mouse models to define immunovirologic determinants of progressive multifocal leukoencephalopathy Crystallographic and Glycan Microarray Analysis of Human Polyomavirus 9 VP1 Identifies N-Glycolyl Neuraminic Acid as a Receptor Candidate In Vitro and In Vivo Models for the Study of Human Polyomavirus Infection The Merkel cell polyomavirus minor capsid protein A cornucopia of human polyomaviruses.BK virus nephropathy in renal transplant recipients.Antibodies to BK virus in children prior to allogeneic hematopoietic cell transplant BK polyomavirus genotypes represent distinct serotypes with distinct entry tropism.Serological cross-reactivity between human polyomaviruses.The human JC polyomavirus (JCPyV): virological background and clinical implications.45 years after the discovery of human polyomaviruses BK and JC: Time to speed up the understanding of associated diseases and treatment approaches.Commercially available immunoglobulins contain virus neutralizing antibodies against all major genotypes of polyomavirus BK.Molecular characterization of BK virus in patients infected with human immunodeficiency virus.BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies.Anti-JCV serology during natalizumab treatment: Review and meta-analysis of 17 independent patient cohorts analyzing anti-John Cunningham polyoma virus sero-conversion rates under natalizumab treatment and differences between technical and biologica Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation.Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values.JC polyomavirus mutants escape antibody-mediated neutralization.Assembly and Purification of Polyomavirus-Like Particles from Plants.Genotypic diversity of polyomaviruses circulating among kidney transplant recipients in Kuwait.Neutralizing Antibody-Mediated Response and Risk of BK Virus-Associated Nephropathy.PML risk stratification using anti-JCV antibody index and L-selectin.Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus Evolution.Antibodies Can Extenuate Polyomavirus Infections.

P2860

Q21285083-32262C68-2824-4C9E-A1A6-81EE25D841B8 Q26859307-72DF22A9-E160-431D-B900-4825236D0998 Q27682301-5338B395-B082-44C2-81DF-D7ADB9A09026 Q28074684-5A2205E9-77FB-4CF1-B60F-15691CCE21B1 Q28681646-2675ED69-FC19-4C44-8972-53A86318DCEA Q34332024-7FD20B45-1AA4-4F7F-BA6B-0CBBA0CE5901 Q34509585-1D4F95AC-60C2-46F4-9E67-7CD1D3E7637B Q35889274-F2D24C22-98A0-4C7C-AB8B-7C3E07C540EA Q37123173-61A9DD01-67BC-4BB9-A538-0EC8E6D48929 Q38104692-6B39D5A2-CC1D-4F0C-8B9D-BB841B6E5F60 Q38115572-C33E29F6-4911-4B62-A1B4-628DCD78BF7E Q38801394-CF128D25-BF64-425E-83B4-56814DE4BD48 Q38904012-0D243B2D-BAD9-4876-9EC5-96EE68DF0228 Q39120771-299B2587-EED7-4A6A-ABE1-FA73BE1B2328 Q39180715-0B30601E-0EC6-4D31-8A47-A1DE9C82439A Q40067748-BA86C327-6849-4275-8059-969BF6D64D9F Q40649540-19DFFF1B-E68E-451E-A317-57A3558692E3 Q40928069-F7776722-5112-41A5-B8DB-D5670A2ED635 Q40984700-C360F3A5-CA8A-46C6-B083-427F19C3D2F1 Q41582566-4BCA2F42-0A37-4FFF-A664-94F85FC4C301 Q44743039-A2515A58-5B04-4F9E-971C-D34D642CC927 Q45326184-D20D72E9-5833-4832-9CEB-5931E64AB8F1 Q48938768-4DAA906A-B5AB-4778-9016-B6479F3DFA21 Q54215480-600D9636-C925-4D3A-A391-926182F2967A Q54269243-5B75839C-4824-4817-AF36-D77694D9C06F

P2860

Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients

http://www.wikidata.org/entity/Q34236633

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients

@ast

Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients

@en

Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients

@nl

type

label

Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients

@ast

Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients

@en

Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients

@nl

prefLabel

Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients

@ast

Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients

@en

Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients

@nl

P1433

Q34236633-4DAE869B-5DE2-437F-B77C-ABA0F51C1DF2

P1476

Q34236633-04886CC2-E3B6-490E-B98A-33CA16A1D7DA

P2093

Q34236633-018AD31B-4F5B-46D2-842C-D4D432435D09

Q34236633-22A1553C-AF9B-4E02-BCF6-74DB6CA2499A

Q34236633-868F38C2-F5ED-471B-9539-330E3841F9B9

Q34236633-E616D355-273D-4904-8A3E-9C29A8E73FD9

Q34236633-F2AD2D46-06D8-4A70-8FD5-08B5D9EBC35E

P2860

Q34236633-00C05CA4-D3BD-4FD7-A762-5FC3945410DA

Q34236633-01341925-D623-4E2C-A07E-8200BF624C84

Q34236633-043074D0-A059-4925-A4DC-29983F525C36

Q34236633-072F3266-7394-464A-A3BE-156848B41542

Q34236633-0ACAFC42-41EC-4ADE-9982-6CD6F0B89CA0

Q34236633-0C45F237-C941-4E27-96F7-8D8DF5A8B0E1

Q34236633-0E9721EF-ADBD-4FBB-9F17-0E8FA78FD685

Q34236633-13CAC3D5-FFAA-446C-A61F-55F0238FD467

Q34236633-14013FF4-7315-4361-B27D-E98EE2D8F7B4

Q34236633-152F5661-1655-4E26-A699-BE6CFE8B4E2B

P304

Q34236633-E006314D-E6D0-4BBA-B32F-BBE800746F42

P31

Q34236633-71DEAA03-747A-4649-B52A-087377E5FEC9

P356

Q34236633-A6314EDE-0453-4551-BD0A-FB4CFD4F686F

P433

Q34236633-D875A2B0-978A-43B2-905D-C6574A1033E1

P478

Q34236633-AC358466-5878-42BE-96BE-20FFB350A912

P50

Q34236633-5BA6F6C2-13A0-4FD4-A515-6E7A3EB618C8

Q34236633-F168AACF-7297-4C09-98B9-FF6E8C63CE7E

P577

Q34236633-EFC52A40-CE51-4835-AA7E-24C23D6C3877

P5875

Q34236633-12494172-1E07-41B5-9503-D672E4516858

P698

Q34236633-A312BD34-2FC9-4123-9FE9-31021A1DE688

P932

Q34236633-84F2C8E2-97B3-4E8B-A84F-6E0E50AD368E

P356

JOURNAL.PPAT.1002650

P1433

P1476

Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients

@en

P2093

Daniel C Brennan

http://www.w3.org/2001/XMLSchema#string

Gregory A Storch

http://www.w3.org/2001/XMLSchema#string

Nicolas Cuburu

http://www.w3.org/2001/XMLSchema#string

Parmjeet S Randhawa

http://www.w3.org/2001/XMLSchema#string

Raphael P Viscidi

http://www.w3.org/2001/XMLSchema#string

P2860

Quantitation of human seroresponsiveness to Merkel cell polyomavirus

Structure-Function Analysis of the Human JC Polyomavirus Establishes the LSTc Pentasaccharide as a Functional Receptor Motif

The structure of simian virus 40 refined at 3.1 A resolution

SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling

Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors

Evolution of BK virus based on complete genome data.

Neutralizing antibodies against HIV-1: can we elicit them with vaccines and how much do we need?

Glycosaminoglycans and sialylated glycans sequentially facilitate Merkel cell polyomavirus infectious entry.

Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells.

In vivo mechanisms of vaccine-induced protection against HPV infection.

P304

e1002650

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PPAT.1002650

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Christopher B. Buck

Diana V. Pastrana

P577

2012-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224285169

http://www.w3.org/2001/XMLSchema#string

P698

22511874

http://www.w3.org/2001/XMLSchema#string

P932

3325208

http://www.w3.org/2001/XMLSchema#string